Oliver Luxxe Assets LLC Charles River Laboratories International, Inc. Transaction History

Oliver Luxxe Assets LLC

  • $528 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021
SELL
$249.67 - $299.48 $1.33 Million - $1.59 Million
-5,317 Closed
0 $0
Q4 2020

Feb 04, 2021
BUY
$222.0 - $252.62 $844,044 - $960,461
3,802 Added 250.96%
5,317 $1.47 Million
Q3 2020

Oct 20, 2020
SELL
$175.56 - $226.45 $2,106 - $2,717
-12 Reduced 0.79%
1,515 $343,000
Q1 2020

Apr 21, 2020
BUY
$98.9 - $178.34 $151,020 - $272,325
1,527 New
1,527 $216,000

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email